Home Page / News / Saadia Pharmaceuticals’ Team Publishes Acute Study on Lybalvi® (Alkermes Pharmaceuticals) for Rapid Weight Loss in Schizophrenia or Bipolar I Disorder
Saadia Pharmaceuticals’ Team Publishes Acute Study on Lybalvi® (Alkermes Pharmaceuticals) for Rapid Weight Loss in Schizophrenia or Bipolar I Disorder
